Open access
A Single Suprachoroidal Injection of AXT107 (Gersizangitide), a Multimodal, Long-Acting Integrin-Disrupting Peptide, in Patients with Neovascular Age-Related Macular Degeneration: Results of the Phase 1/2a DISCOVER Trial
Niranjan B. Pandey
Adam C. Mirando
David R. P. Almeida
S. Dang
D. Lally
William Z. Bridges
P. Campochiaro
A. Popel
J. J. Green
Medicine